全球权威调研机构Technavio最新报告显示，预计在2013到2018年全球基因组学和蛋白组学分析仪器市场将保持7.83%的复合年增长率。
基因组学研究的是基因及其功能，蛋白质组学研究的是蛋白质组或组蛋白的结构和功能，两者均使用分子生物学和生物信息学的工具和技术。基因组学通过绘制基因和DNA序列来了解基因组的结构和功能。一个蛋白质组是一个基因组在特定时间内表达的一整套蛋白质。蛋白质组学主要涉及的是使用分子生物学、生物化学和遗传学来分析蛋白质，这些蛋白质是通过基因编码而来。蛋白质是所有细胞的主要组分，而且控制细胞的不同功能特性。基因组和蛋白质组结构或功能的缺陷可能导致疾病，因此基因组学和蛋白组学技术在科研、新药研发、疾病诊断中发挥着重要作用。这些应用都需要基因和蛋白缺陷的识别和研究，而基因组和蛋白质组的蛋白质分离、净化、识别、量化和分析都需要仪器、试剂和软件。基因组学和蛋白质组学用到多种分析仪器，但应用最广泛的是色谱系统、质谱系统、PCR系统和下一代测序系统。
这个市场发展的主要推动力为基因组学和蛋白组学技术的完善，主要挑战在于基因组学和蛋白组学知识的缺乏，主要趋势为聚焦于药物研发和疾病诊断。
The global market for genomics and proteomics analysis instruments is expected to grow at a compound annual rate of 7.83 percent between 2013 and 2018, according to a new report by Technavio, a leading global research firm.
Genomics is the study of genes and their functions, proteomics is the study of protein structure and function of the protein group or group, both the use of tools and techniques of molecular biology and bioinformatics. Genomics works by mapping genes and DNA sequences to understand the structure and function of the genome. A proteome is a set of proteins expressed by a genome at a specific time. Proteomics involves the use of molecular biology, biochemistry and genetics to analyze proteins encoded by genes. Protein is the main component of all cells and controls the different functional properties of cells. Defects in the structure or function of genomes and proteomics may lead to diseases, so genomics and proteomics technologies play an important role in scientific research, new drug development and disease diagnosis. These applications require the identification and study of gene and protein defects, and the separation, purification, identification, quantification and analysis of the genome and proteome proteins require instruments, reagents and software. Genomics and proteomics are used in a variety of analytical instruments, but the most widely used are chromatographic systems, mass spectrometry systems, PCR systems and next-generation sequencing systems.
The main driving factor for the growth of the market for the perfection of the technology of genomics and proteomics, the main challenge is the lack of knowledge of genomics and proteomics, the main trend to focus on drug research and disease diagnosis.
